Varicella Zoster-Induced Severe Diabetic Ketoacidosis
DOI:
https://doi.org/10.66266/inajemd.v2i1.47Keywords:
Varicella, diabetic ketoacidosis, vaccine, complicationAbstract
Diabetic ketoacidosis (DKA) is a life-threatening complication of diabetes. There are not many cases reported relate to this case. This case report aims to present a case of DKA which is a common and potentially life-threatening complication in T1DM and can be the first sign of undiagnosed diabetes. A 36-year-old female presented with altered mental status and breathing difficulty. The patient's three children had recently contracted varicella (chickenpox). The patient was diagnosed with type 1 diabetes mellitus 8 months ago, with irregular adherence to treatment. Vital signs included a blood pressure of 84/60 mmHg on norepinephrine at 12 mcg/min, heart rate of 135 bpm, respiratory rate of 33 breaths/min, and temperature of 38.9°C. Physical examination revealed multiple lenticular, circumscribed vesicles with an erythematous base across the entire body. Laboratory results showed leukocytosis (leukocytes: 16,000 x 103/μL), hyperglycemia (random blood glucose: 273 mg/dL), severe metabolic acidosis (pH: 7.002, HCO3: 5.7 mEq/L, BE: -23.6 mEq/L), hypoxemia (pO2: 38 mmHg, SaO2: 52.8%), hypoalbuminemia (albumin: 3.48 g/dL), and stage I acute kidney injury (creatinine: 1.36 mg/dL). Urinalysis revealed the presence of ketone bodies. The patient was subsequently diagnosed with severe diabetic ketoacidosis, varicella zoster infection, septic shock with multiorgan failure, and type 1 diabetes mellitus. Despite initial treatment efforts, the patient’s condition continued to deteriorate, with no signs of clinical improvement. After 3 days, the patient deceased. In conclusion, although varicella zoster infection is an uncommon precipitant of DKA, the present case report highlights the critical role of varicella zoster vaccination and optimal glycemic control in DMT1 to prevent infection-related DKA progression.
Downloads
References
1. The Lancet. Diabetes: a defining disease of the 21st century. The Lancet. 2023 Jun;401(10394):2087.
2. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and
country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022 Jan;183:109119.
3. Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2023 Jul;402(10397):203–34.
4. Benouda S, Ziani I, Assarrar I, Rouf S, Latrech H. Predictive factors of diabetic ketoacidosis in patients with newly onset type 1 diabetes: A single center study. Diabetes Epidemiology and Management. 2024 Oct;16:100231.
5. Alourfi Z, Homsi H. Precipitating factors, outcomes, and recurrence of diabetic ketoacidosis at a university hospital in Damascus. Avicenna J Med. 2015 Jan 9;05(01).
6. Mahesh M. The Study of Different Clinical Pattern of Diabetic Ketoacidosis and Common Precipitating Events and Independent Mortality Factors. Journal of Clinical and Diagnostic Research. 2017;11(4):OC42–6.
7. Hamed ZS, Gawaly A, Abbas K, El Ahwal L. Epidemiology of infection as a precipitating factor for diabetic ketoacidosis at Tanta University Hospital. Tanta Medical Journal. 2017;45(2):68.
8. Al-Obaidi AH, Alidrisi HA, Mansour AA. Precipitating Factors for Diabetic Ketoacidosis among Patients with Type 1 Diabetes Mellitus: The Effect of Socioeconomic Status. Dubai Diabetes and Endocrinology Journal. 2019;25(1–2):52–60.
9. Chávez-Reyes J, Escárcega-González CE, Chavira-Suárez E, León-Buitimea A, VázquezLeón P, Morones-Ramírez JR, et al. Susceptibility for Some Infectious Diseases in Patients With Diabetes: The Key Role of Glycemia. Front Public Health. 2021 Feb 16;9.
10. Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: A review of pathogenesis. Indian J Endocrinol Metab. 2012;16(7):27.
11. Critchley JA, Carey IM, Harris T, DeWilde S, Hosking FJ, Cook DG. Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study. Diabetes Care. 2018 Oct 1;41(10):2127–35.
12. Rao VD, Pradhan B, Mallikarjuna Y, Reddy R. Clinical profile of diabetic ketoacidosis in adults. Health Renaissance. 2012 Jul 28;10(2):80–6.
13. Mizu D, Nishida H, Matsuoka Y, Ariyoshi K. Visceral disseminated varicella zoster infection: a rare cause of acute abdomen in a patient with well-controlled diabetes mellitus—a case report. BMC Infect Dis. 2022 Dec 3;22(1):215.
14. Manan A, Nouman S, Naseer S, niaz H, Ali A, Daftani MH, et al. Complicated Presentation of Diabetic Ketoacidosis (DKA) with Concurrent Infection. Journal of Population and Therapeutics and Clinical Pharmacology. 2024;
15. Riley DS, Barber MS, Kienle GS, Aronson JK, von Schoen-Angerer T, Tugwell P, et al. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol. 2017 Sep;89:218–35.
16.
Puttanna A, Padinjakara R. Diabetic ketoacidosis in type 2 diabetes mellitus. Practical Diabetes. 2014 May 9;31(4):155–8.
17. Lundqvist MH, Pereira MJ, Almby K, Hetty S, Eriksson JW. Regulation of the Cortisol Axis, Glucagon, and Growth Hormone by Glucose Is Altered in Prediabetes and Type 2 Diabetes. J Clin Endocrinol Metab. 2024 Jan 18;109(2):e675–88.
18. Zhang J, Zheng Y, Martens L, Pfeiffer AFH. The Regulation and Secretion of Glucagon in Response to Nutrient Composition: Unraveling Their Intricate Mechanisms. Nutrients. 2023 Sep 8;15(18):3913.
19. Kuo T, McQueen A, Chen TC, Wang JC. Regulation of Glucose Homeostasis by Glucocorticoids. In 2015. p. 99–126.
20. Svart M, Kampmann U, Voss T, Pedersen SB, Johannsen M, Rittig N, et al. Combined Insulin Deficiency and Endotoxin Exposure Stimulate Lipid Mobilization and Alter Adipose Tissue Signaling in an Experimental Model of Ketoacidosis in Subjects With Type 1 Diabetes: A Randomized Controlled Crossover Trial. Diabetes. 2016 May 1;65(5):1380–6.
21. Bae J, Lee BW. Association between Impaired Ketogenesis and Metabolic-Associated Fatty Liver Disease. Biomolecules. 2023 Oct 11;13(10):1506.
22. Awchi M, Singh KD, Brenner SB, Burckhardt MA, Hess M, Zeng J, et al. Metabolic trajectories of diabetic ketoacidosis onset described by breath analysis. Front Endocrinol (Lausanne). 2024 May 1;15.
23. van Niekerk G, Davis T, Patterton H, Engelbrecht A. How Does Inflammation‐Induced Hyperglycemia Cause Mitochondrial Dysfunction in Immune Cells? BioEssays. 2019 May 10;41(5).
24. van Loo G, Bertrand MJM. Death by TNF: a road to inflammation. Nat Rev Immunol. 2023 May 15;23(5):289–303.
25. Tanaka T, Narazaki M, Kishimoto T. IL-6 in Inflammation, Immunity, and Disease. Cold Spring Harb Perspect Biol. 2014 Oct 1;6(10):a016295–a016295.
26. Lainampetch J, Panprathip P, Phosat C, Chumpathat N, Prangthip P, Soonthornworasiri N, et al. Association of Tumor Necrosis Factor Alpha, Interleukin 6, and C-Reactive Protein with the Risk of Developing Type 2 Diabetes: A Retrospective Cohort Study of Rural Thais. J Diabetes Res. 2019 Aug 8;2019:1–9.
27. Karavanaki K, Karanika E, Georga S, Bartzeliotou A, Tsouvalas M, Konstantopoulos I, et al. Cytokine response to diabetic ketoacidosis (DKA) in children with type 1 diabetes (T1DM). Endocr J. 2011;58(12):1045–53.
28. Suwita CS, Johan M, Tahapary DL, Darmowidjojo B. Herpes Zoster SebagaiPencetusKetoasidosisDiabetikum (KAD). JurnalPenyakit Dalam Indonesia. 2019 Jan 1;5(4).
29. Tesfaye S, Cullen DR, Wilson M, Woolley PD. Diabetic ketoacidosis precipitated by genital herpes infection. Diabetes Res Clin Pract. 1991;13(1991):83–4.
30. Arruti M, Piñeiro LD, Salicio Y, Cilla G, Goenaga MA, López de Munain A. Incidence of varicella zoster virus infections of the central nervous system in the elderly: a large tertiary hospital-based series (2007–2014). J Neurovirol. 2017 Jun 21;23(3):451–9.
31. Herlin LK, Hansen KS, Bodilsen J, Larsen L, Brandt C, Andersen CØ, et al. Varicella Zoster Virus Encephalitis in Denmark From 2015 to 2019—A Nationwide Prospective Cohort Study. Clinical Infectious Diseases. 2021 Apr 8;72(7):1192–9.
32. Blonde L, Umpierrez GE, Reddy SS, McGill JB, Berga SL, Bush M, et al. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update. Endocrine Practice. 2022 Oct;28(10):923–1049.
33. Hata A, Inoue F, Hamamoto Y, Yamasaki M, Fujikawa J, Kawahara H, et al. Efficacy and safety of live varicella zoster vaccine in diabetes: a randomized, double‐blind, placebocontrolled trial. Diabetic Medicine. 2016 Aug 29;33(8):1094–101.
34. Government of Canada. Updated Recommendations on the Use of Herpes Zoster Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI). 2018.
35. Anderson TC, Masters NB, Guo A, Shepersky L, Leidner AJ, Lee GM, et al. Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022. Morbidity and Mortality Weekly Report. 2022 Jan 21;71(3):80–4.
36. Dooling KL, Guo A, Patel M, Lee GM, Moore K, Belongia EA, et al. Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines. Morbidity and Mortality Weekly Report. 2018 Jan 26;67(3):103–8.
37. McKay SL, Guo A, Pergam SA, Dooling K. Herpes Zoster Risk in Immunocompromised Adults in the United States: A Systematic Review. Clinical Infectious Diseases. 2020 Oct 23;71(7):e125–34.
38. Patil A, Goldust M, Wollina U. Herpes zoster: A Review of Clinical Manifestations and Management. Viruses. 2022 Jan 19;14(2):192.
39. Giannelos N, Curran D, Nguyen C, Kagia C, Vroom N, Vroling H. The Incidence of Herpes Zoster Complications: A Systematic Literature Review. Infect Dis Ther. 2024 Jul 19;13(7):1461–86.
40. Johnson RW, Alvarez-Pasquin MJ, Bijl M, Franco E, Gaillat J, Clara JG, et al. Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. Ther Adv Vaccines. 2015 Jul 19;3(4):109–20.
41. Racine É, Gilca V, Amini R, Tunis M, Ismail S, Sauvageau C. A systematic literature review of the recombinant subunit herpes zoster vaccine use in immunocompromised 18–49 year old patients. Vaccine. 2020 Sep;38(40):6205–14.
42. Alexander KE, Tong PL, Macartney K, Beresford R, Sheppeard V, Gupta M. Live zoster vaccination in an immunocompromised patient leading to death secondary to disseminated varicella zoster virus infection. Vaccine. 2018 Jun;36(27):3890–3.
43. Li-Kim-Moy J, Phillips A, Morgan A, Glover C, Jayasinghe S, Hull BP, et al. Disseminated varicella zoster virus
infection following live attenuated herpes zoster vaccine: descriptive analysis of reports to Australia’s spontaneous vaccine pharmacovigilance system, 2016– 2020. BMJ Open. 2023 Jan 27;13(1):e067287.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 InaJEMD - Indonesian Journal of Endocrinology Metabolism and Diabetes
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain copyright and grant the Indonesian Journal of Endocrinology, Metabolism and Diabetes (InaJEMD) the right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
© Indonesian Journal of Endocrinology, Metabolism and Diabetes (InaJEMD). Published by the Indonesian Society of Endocrinology (PERKENI).
